TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Consider These 3 Unlikely Candidates for Growth
Bank Stocks
Time to Get Behind the Bank of Weed’s Growth
Dividend Stocks
Behold the Anti-Yield-Hog Portfolio
Investing
Cannabis Growth Investors: Why the Best Is Yet to Come
Investing
Canada’s Top Growth Companies
Dividend Stocks
5 High-Growth Stocks That Have Seen Sales Triple in 2 Years and Could Still Grow More!
Investing
Cannabis Investors: Will Excise Taxes Push Demand to the Black Market?
Investing
Breaking Down Alberta’s Expected Laws for Cannabis: What it Means for Investors
Investing
Legal Marijuana Could Be a Major Tailwind for This Iconic Canadian Company
Investing
With Marijuana Legalization Around the Corner, Here’s Why I Like Canopy Growth Corp. More Than Ever
Investing
Where to Invest Before Canada Enters a Recession